Successful treatment with ustekinumab in a pediatric PRP case without CARD14 mutation

Key Points

• The aim is to evaluate the effectiveness of ustekinumab in treating pediatric palmoplantar pustulosis (PRP) without a CARD14 mutation.
• Observational case report on a pediatric patient
• Administration of ustekinumab as the primary treatment
• Assessment of treatment outcomes and side effects
• Notable improvement in dermatological symptoms observed
• Significant reduction in pustule formation reported
• No adverse effects linked to treatment identified